Mercaptor Introduces Powerful CAPTON™️ Platform for Precision Neurology

New Technology Addresses Brain Trauma Including Alzheimer’s, TBI, and Epilepsy SAN FRANCISCO, Jan. 5, 2024 /PRNewswire-PRWeb/ — Mercaptor Inc, a privately held pharmaceutical company, today announced a breakthrough platform for the CNS. The pivotal technology overcomes challenges that…

Click here to view original post